Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15665226 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Device: Ablation with the NanoKnife Low Energy Direct Current (LEDC) System
2 Completed Radiofrequency Ablation of Pulmonary Tumors Response Evaluation
Conditions: Non Small Cell Lung Cancer;   Pulmonary Metastases
Intervention: Device: RF ablation (Rita Medical Systems Model 1500x)

Indicates status has not been verified in more than two years